Improved liver function and decreased hepatitis C viral load after tacrolimus was replaced by cyclosporine

Transplantation Proceedings

Volumn 37, Issue 6, 2005, Pages 2871-2872

  Lorho, R ^a   Turlin, B ^a   De Lajarte Thirouard, A S ^a   Camus, C ^a   Lakehal, M ^a   Compagnon, P ^a   Meunier, B ^a   Boudjema, K ^a   Messner, M ^a  

^a PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; CYCLOSPORIN; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PEGINTERFERON ALPHA2A; PREDNISONE; RIBAVIRIN; TACROLIMUS;

ADULT; ANTIVIRAL ACTIVITY; CASE REPORT; CONFERENCE PAPER; DISEASE ACTIVITY; DRUG EFFECT; DRUG RESPONSE; DRUG SUBSTITUTION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER CIRRHOSIS; LIVER FUNCTION; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL; RECIPIENT; RECURRENT INFECTION; TREATMENT FAILURE; TREATMENT OUTCOME; VIRUS LOAD; VIRUS REACTIVATION;

EID: 25144484495     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2005.05.019     Document Type: Article

References (3)

1. K. Inoue, K. Sekiyama, M. Yamada Combined interferon alpha2b and cyclosporin A in the treatment of chronic hepatitis C controlled trial J Gastroenterol 38 2003 567
2. K. Watashi, M. Hijikata, M. Hosaka Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes Hepatology 38 2003 1282
3. M. Nakagawa, N. Sakamoto, N. Enomoto Specific inhibition of hepatitis C virus replication by cyclosporin A Biochem Biophys Res Commun 313 2004 42